Cullinan Therapeutics Q4 EPS $(0.77) Beats $(0.82) Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings BeatsNews
Cullinan Therapeutics (NASDAQ:CGEM) reported quarterly losses of $(0.77) per share which beat the analyst consensus estimate of $(0.82) by 6.1 percent. This is a 5.48 percent decrease over losses of $(0.73) per share
Cullinan Therapeutics (NASDAQ:CGEM) reported quarterly losses of $(0.77) per share which beat the analyst consensus estimate of $(0.82) by 6.1 percent. This is a 5.48 percent decrease over losses of $(0.73) per share from the same period last year.